Evidence map›Paper›PMID 40540159›Full record

ArticleDiscover oncology2025

Clinicopathological features and prognostic significance of site-specific metastasis in gastric cancer: a population-based, propensity score-matched analysis.

Xingbiao Huang, Zhe Li, Qiuyan Weng

Abstract read
In one paragraph

Article in Discover oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Xingbiao HuangDepartment of General Surgery, Ningbo No.6, Hospital, Ningbo, 315043, China.
Zhe LiDepartment of Gastroenterology, The First Affiliated Hospital of Ningbo University, Ningbo, 315010, China. fylizhe@nbu.edu.cn.
Qiuyan WengDepartment of Gastroenterology, The First Affiliated Hospital of Ningbo University, Ningbo, 315010, China. fywengqiuyan@nbu.edu.cn.

Funding

the Medical and Health Research Project of Zhejiang Province 2023RC262
6 · The paper itself

Abstract

objectiveDistant metastasis complicates gastric cancer management and worsens patient outcomes. Understanding the clinicopathological characteristics and prognostic impact of site-specific metastases is crucial for improving treatment strategies and survival prediction.

methodsData from 8338 metastatic gastric cancer patients (2010-2015) were retrieved from the SEER database. Patients were categorized by metastatic organ involvement. Chi-square tests analyzed clinicopathological differences. Cancer-specific survival (CSS) was assessed using Kaplan-Meier curves and the log-rank test. Independent prognostic factors were identified through Cox regression analysis. Propensity score matching minimized group heterogeneity.

resultsThe liver was the most common metastatic site (43.20%). Patients with bone, brain, or lung metastases had significantly shorter CSS compared to those without these metastases. CSS differences between liver metastasis and non-metastasis were not significant. Propensity score matching confirmed shorter CSS in patients with bone and lung metastases. Single-site metastasis had a better prognosis than multiple-site metastasis, with liver-only metastasis showing the best survival and bone-only metastasis the worst. Multivariate Cox regression identified bone, brain, and lung metastases, age, histology, tumor grade, T stage, N stage, primary tumor resection, and chemotherapy as independent prognostic factors.

conclusionsThe metastatic site significantly influences the prognosis of gastric cancer. Single-site metastasis offers a survival advantage over multiple-site involvement, with liver metastasis showing a better prognosis and bone metastasis the worst. These findings emphasize the importance of site-specific management and the prognostic value of metastatic patterns in gastric cancer.

Indexed as

Cancer-specific survivalGastric cancerMetastasisSEER

Identifiers

PMID40540159
PMCPMC12181138

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.